Literature DB >> 12074395

Guidelines on bladder cancer.

Willem Oosterlinck1, Bernard Lobel, Gerhard Jakse, Per-Uno Malmström, Michael Stöckle, Cora Sternberg.   

Abstract

OBJECTIVES: On behalf of the European Association of Urology (EAU) guidelines for diagnosis, therapy and follow-up of bladder cancer patients were established. Criteria for recommendations were evidence based, and included aspects of cost-effectiveness and clinical feasibility.
METHOD: A systematic literature research using Medline Services was conducted. References were weighted by a panel of experts.
RESULTS: TNM 1997 classification and WHO grading 1998 are recommended. Recommendations are developed for diagnosis for bladder cancer in general, treatment of superficial and infiltrative bladder cancer, and follow-up after different types of treatment modalities, such as intravesical instillations, radical cystectomy, urinary diversions, radiotherapy and chemotherapy.

Entities:  

Mesh:

Year:  2002        PMID: 12074395     DOI: 10.1016/s0302-2838(01)00026-4

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  65 in total

1.  Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients.

Authors:  Meng Chen; Jian Gu; George L Delclos; Ann M Killary; Zhen Fan; Michelle A T Hildebrandt; Robert M Chamberlain; H Barton Grossman; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2010-06-07       Impact factor: 4.944

2.  Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma.

Authors:  Ying-Li Lin; Xiao-Qiang Liu; Wen-Ping Li; Guang Sun; Chun-Ting Zhang
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

3.  Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.

Authors:  Tomoko Hayashi; Brian Crain; Maripat Corr; Michael Chan; Howard B Cottam; Roberto Maj; Alcide Barberis; Lorenzo Leoni; Dennis A Carson
Journal:  Int J Urol       Date:  2010-03-11       Impact factor: 3.369

4.  [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].

Authors:  S Denzinger; A Hartmann; F Hofstaedter; R Knuechel; P J Wild; D Zaak; C Stief; W F Wieland; R Stoehr; M Burger
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

Review 5.  Photodynamic diagnostics of bladder tumors.

Authors:  Stefan Denzinger; Maximilian Burger
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

6.  [Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer?].

Authors:  H Suttmann; M Retz; J E Gschwend; M Stöckle
Journal:  Urologe A       Date:  2007-10       Impact factor: 0.639

7.  Comparison of the short-term efficacy of sequential treatment with intravesical single-port laparoscopic partial cystectomy with bladder preservation or open partial cystectomy in combination with cisplatin plus gemcitabine chemotherapy.

Authors:  Hai-Xing Mai; Jun-LE Liu; Shu-Jun Pei; L I Zhao; Nan Qu; Jin-Kai Dong; Biao Chen; Ya-Lin Wang; Cheng Huang; Li-Jun Chen
Journal:  Exp Ther Med       Date:  2015-04-24       Impact factor: 2.447

8.  [Complete resection of urothelial cancer metastases with curative intent].

Authors:  J Lehmann; H Suttmann; P Albers; B Volkmer; J E Gschwend; G Fechner; M Spahn; A Heidenreich; A Odenthal; C Seif; N Nürnberg; C Wülfing; C Greb; T Kälble; M-O Grimm; C F Fieseler; S Krege; M Retz; H Schulte-Baukloh; M Gerber; M Hack; J Kamradt; M Stöckle
Journal:  Urologe A       Date:  2009-02       Impact factor: 0.639

9.  Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in China.

Authors:  Hai Tao Niu; Haitao Niu; Shi Xiu Shao; Shixiu Shao; Zong Liang Zhang; Zongliang Zhang; Shuai Wu; Bo Cheng; De Quan Pang; Dequan Pang; Ya Jun E; Yajun E; Sheng Guo Dong; Shengguo Dong; Guang Sun; Ji Wu Chang; Jiwu Chang
Journal:  Int Urol Nephrol       Date:  2008-09-23       Impact factor: 2.370

10.  Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling.

Authors:  Yigang Qian; Junfang Deng; Haiyang Xie; Lei Geng; Lin Zhou; Yan Wang; Shenyong Yin; Xiaowen Feng; Shusen Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-30       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.